Novo Nordisk Leans Into Affordability Amid Rising Competition - Novo Nordisk ( NYSE:NVO )
Novo Nordisk A/S ( NYSE:NVO ) announced on Monday that Wegovy ( semaglutide ) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited-time price of $199 per month to new self-pay patients between now and March 31, 2026.
Is Teladoc Health Accelerating Growth Through Global Expansion?
TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.
NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock?
Novo Nordisk stock falls 10% in three months as guidance cuts, GLP-1 rivalry and looming U.S. price resets cloud growth and elevate execution risks.
CVS Health Posts Strong Q3 Earnings: How to Play the Stock Now?
CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.
Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Looms
A surprising office-sector exit by a steady fund may reveal more about opportunity cost than pessimism.
Edible Garden ( EDBL ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Friday, November 14, 2025 at 8 a.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
FIRST FIELD GUIDE TO AUSTIN'S MUSIC SCENE NOW AVAILABLE
At Austin Visitor Center, Five Musicians Discuss What It Takes to Keep the Live Music Capital of the World® Alive and Well Half of net proceeds benefit HAAM's mission to provide healthcare access to working musicians
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
These companies are demonstrating their ability to deal with significant business risks.
3 Stocks That Have Made Epic Comebacks in 2025
Last year was a bad one for these stocks, but buying them on weakness would have proven to be a great move for investors.
A Look Into CVS Health Inc's Price Over Earnings - CVS Health ( NYSE:CVS )
Looking into the current session, CVS Health Inc. ( NYSE:CVS ) shares are trading at $79.86, after a 0.01% decrease. Over the past month, the stock fell by 0.99%, but over the past year, it actually spiked by 44.98%.
Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch - CVS Health ( NYSE:CVS ) , Eli Lilly ( NYSE:LLY )
Eli Lilly & Co. ( NYSE:LLY ) is reportedly dropping CVS Health Inc.'s ( NYSE:CVS ) drug benefit plan for its employees.
CVS/Aetna Medicare Advantage Plans Policy Holders Have Opportunity to Join Investigation into Improper Claim Denial for Post-Acute Care with the Schall Law Firm
LOS ANGELES, Nov. 11, 2025 ( GLOBE NEWSWIRE ) -- The Schall Law Firm, a national litigation firm, announces that it is investigating claims on behalf of policyholders of Aetna Medicare Advantage plans through CVS Health Corporation ( "CVS" ) for breach of contract and related violations of state ...
Claire Rosinkranz Partners with Native and Billboard to Spread Holiday Cheer with an Original Jingle and Limited-Edition Collection
Bringing her signature charm to the season, Claire Rosinkranz debuts "It's That Native Holiday Cheer," a festive ode to Native's cozy holiday collection.
CVS Health Lifts Adjusted EPS Outlook: What's Driving It?
CVS raises its full-year EPS outlook after a strong quarter, driven by gains across all segments and solid pharmacy growth.
CVS Health Is Soaring 75% This Year. And the Stock Still Looks Cheap.
The company replaced its CEO last year, and the turnaround has been going well.
How is Teladoc Health Placed in the Growing Telemedicine Market?
Teladoc Health is expanding its AI-powered virtual care capabilities as the telemedicine market surges toward massive U.S. growth.
ARS Pharma SPRY Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Monday, Nov. 10, 2025 at 8:30 a.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.
Can CVS Health Maintain Its Growth Through the End of 2025?
The company's prospects are looking up.
LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs
Lilly's Mounjaro and Zepbound continue to power growth as new launches boost momentum amid rising obesity competition.
Celsius Holdings Q3 2025 Earnings Call Transcript - Celsius Holdings ( NASDAQ:CELH )
Celsius Holdings, Inc. ( NASDAQ:CELH ) reported third-quarter financial results on Thursday. The transcript from the company's earnings call has been provided below. CELH is encountering selling pressure. Check the full analysis here.
Zevia ( ZVIA ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, November 5, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Realty Income Reported Earnings Monday. Here's What Investors Need to Know.
The post-earnings dip in the share price looks like an opportunity to get this best-in-class REIT at a slight discount.
Novo Nordisk Q3 2025 Earnings Call Transcript - Novo Nordisk ( NYSE:NVO )
Novo Nordisk A/S ( NASDAQ:NVO ) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below. NVO is having a challenging session. See if it is worth your attention here.
[Latest] Global Floor POP Display Market Size/Share Worth USD 9.1 Billion by 2034 at a 6.2% CAGR: Custom Market Insights ( Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis )
Austin, TX, USA, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- Custom Market Insights has published a new research report titled "Floor POP Display Market Size, Trends and Insights By Material Type ( Corrugated Cardboard, Foam Board, Metal, Acrylic, Wood, Others ) , By Display Type ( Standees, Dump Bins, ...
How to Play Teladoc Health Stock Post Q3 Results: Buy, Hold or Sell?
Teladoc Health's Q3 results beat estimates, but revenues dipped and losses widened, attributed to soft performance at BetterHelp.
Investors Heavily Search CVS Health Corporation ( CVS ) : Here is What You Need to Know
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
How Compound Interest Can Help You Retire a Millionaire -- Even on a Modest Income
It's definitely possible to become a multimillionaire -- even if you're not pulling in six figures annually.
Colgate ( CL ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Friday, Oct. 31, 2025 at 8:30 a.m. ETChairman, President, and Chief Executive Officer - Noel R. WallaceContinue reading ...
What the Options Market Tells Us About CVS Health - CVS Health ( NYSE:CVS )
High-rolling investors have positioned themselves bearish on CVS Health ( NYSE:CVS ) , and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data.
Final Results
Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining31 October ...
Is Invesco S&P 500 Pure Value ETF ( RPV ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Moelis ( MC ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Oct. 29, 2025, at 5 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Vantiva - Third Quarter 2025 Revenues
Press Release ...
Eli Lilly ( LLY ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, October 30, 2025 at 10 a.m. ETChairman and Chief Executive Officer - David A. RicksContinue reading ...
Teladoc Health Posts Mixed Results For Q3, Shares Move Lower - Teladoc Health ( NYSE:TDOC )
Teladoc Health Inc ( NYSE:TDOC ) reported financial results for the third quarter after the closing bell on Wednesday. Here's a rundown of the telehealth company's report. Q3 Highlights: Teladoc reported third-quarter revenue of $626.44 million, beating analyst estimates of $625.91 million.
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound
Starting in mid-November, cash-paying patients can purchase Zepbound vials at discounts of 50% or more through the retailer's locations or via home delivery.
CVS Health Stock Hits 52 Week High - CVS Health ( NYSE:CVS )
CVS Health Corp ( NYSE:CVS ) on Wednesday reported better-than-expected third-quarter earnings and raised its annual guidance. The company reported sales of $102.87 billion, beating the consensus of $98.84 billion. Total revenues increased 7.8% year-over-year, driven by revenue growth across ...
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up
CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.
CVS Health ( CVS ) Surpasses Q3 Earnings and Revenue Estimates
CVS Health (CVS) delivered earnings and revenue surprises of +17.65% and +4.66%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Why global investment firm Nuveen is betting on this niche real estate subsector
Vacancy rates in the subsector were 7.8% at the start of 2016, but came down to 4.4% by the beginning of this year, according to data from CoStar Group.
CVS beats estimates, hikes guidance as insurance business improves
The third-quarter results mark David Joyner's first full year as CEO of CVS, which had struggled to drive higher profits and improve its stock performance.
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings
Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?
CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.
Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings
Eli Lilly's Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure of pricing and competition.
CVS vs. FMS: Which Healthcare Services Stock Has More Upside?
CVS outpaces FMS in share gains and valuation appeal, with stronger earnings momentum and expanding health services driving its edge.
Cramer's week ahead: Fed meeting and earnings from Big Tech
CNBC's Jim Cramer walked investors through a jam-packed week of earnings season.
Countdown to CVS Health ( CVS ) Q3 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
CVS Health ( CVS ) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, CVS Health (CVS) closed at $81.07, marking a -1.15% move from the previous day.
Why CVS Health ( CVS ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
